TribLIVE

| USWorld


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Wonder drug for hepatitis C has $90,000 price tag

Email Newsletters

Click here to sign up for one of our email newsletters.

Daily Photo Galleries

By The Associated Press
Tuesday, June 17, 2014, 8:36 p.m.
 

WASHINGTON — Your money or your life?

Sovaldi, a new pill for hepatitis C, cures the liver-wasting disease in 9 of 10 patients, but treatment can cost more than $90,000.

Leading medical societies recommend the drug as a first-line treatment, and patients are clamoring for it. But insurance companies and state Medicaid programs are balking at the price. In Oregon, officials propose to limit how many low-income patients can get Sovaldi.

Yet if Sovaldi didn't exist, insurers would still be paying in the mid-to-high five figures to treat the most common kind of hepatitis C, a new pricing survey indicates. Some of the older alternatives involve more side effects, and are less likely to provide cures.

So what's a fair price?

The cost of this breakthrough drug is highlighting cracks in the health care system at a time of heightened budget concerns. The Obama administration has a huge political stake in controlling treatment costs, but its critics may cry rationing.

“People are going to want to try to dodge this hot potato,” says economist Douglas Holtz-Eakin.

For insurers, there's a frustrating twist: For each middle-aged person they pay to cure with Sovaldi, any financial benefits from preventing liver failure are likely to accrue to Medicare, not to them.

More than 3 million Americans carry the hepatitis C virus, and many don't realize it. It's a public health concern since the disease can be transmitted by contact with infected blood, and sometimes through sexual activity. Health officials advise all baby boomers to get tested.

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Nation

  1. Northwest wildfire season begins early
  2. Lion cubs jump hurdles in Gaza Strip in journey to Jordan sanctuary
  3. Diebold, heirs of Prohibition agent Ness squabble over stock find
  4. Ohio got DEA approval to import lethal-injection drugs
  5. Hiring freeze, budget cuts put West Virginia on better footing
  6. Lawsuit in deaths of 19 firefighters in Arizona yields little cash
  7. Suspect in San Francisco pier shooting was deported 5 times, federal authorities say
  8. Solar-powered plane crosses Pacific Ocean
  9. Santorum charter flight tab broke $400K
  10. Record-breaking solar-powered plane lands in Hawaii after flight from Japan
  11. $18.7B record-breaking deal clears path for BP to put Gulf Coast oil spill in rearview mirror